The role of health systems factors in facilitating access to psychotropic medicines: a cross-sectional analysis of the WHO-AIMS in 63 low- and middle-income countries.
<h4>Background</h4>Neuropsychiatric conditions comprise 14% of the global burden of disease and 30% of all noncommunicable disease. Despite the existence of cost-effective interventions, including administration of psychotropic medicines, the number of persons who remain untreated is as...
Guardado en:
Autores principales: | Ryan McBain, Daniel J Norton, Jodi Morris, M Taghi Yasamy, Theresa S Betancourt |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c068df070de74b75a6fb2dbfe8245a62 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Improving Access & Use of Psychotropic Medicines
por: World Health Organization -
Speech and language therapy education in low middle income countries: the what, the where and the who
por: A. Rupert, et al.
Publicado: (2015) -
Health System Predictors of Access to Maternal Health Medicines in Low and Middle Income Countries
por: C.E. Nnorom
Publicado: (2017) -
COULD AN INCREASE IN EDUCATION RAISE INCOME INEQUALITY ?: EVIDENCE FOR LATIN AMERICA
por: Battistón,Diego, et al.
Publicado: (2014) -
PSYCHOTROPIC PROPERTIES OF REMEDY “ADAPTOPHYT-15”
por: M. V. Baldandorzhiyeva, et al.
Publicado: (2012)